Opexa Therapeutics (OPXA) Reports Q3 Loss Per Share of $0.42
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Research and development: 2.17M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Research and development: 2.17M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Opexa Therapeutics (NASDAQ: OPXA) reported Q3 EPS of ($0.42), versus ($1.11) reported last year. Revenue for the quarter came in at $726 thousand, versus $307 thousand reported last year.
For earnings history and earnings-related data on Opexa Therapeutics (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Meta to pay up to $16.68 billion in mass social media settlement
- CrowdStrike Holdings Inc. (CRWD) Tops Q2 EPS by 2c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
